Cargando…
Association of Metabolomic Change and Treatment Response in Patients with Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is the major cause of chronic liver disease, yet cost-effective and non-invasive diagnostic tools to monitor the severity of the disease are lacking. We aimed to investigate the metabolomic changes in NAFLD associated with therapeutic responses. It was condu...
Autores principales: | Lee, Kwang Seob, Cho, Yongin, Kim, Hongkyung, Hwang, Hyunkyeong, Cho, Jin Won, Lee, Yong-ho, Lee, Sang-Guk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220113/ https://www.ncbi.nlm.nih.gov/pubmed/35740238 http://dx.doi.org/10.3390/biomedicines10061216 |
Ejemplares similares
-
State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis
por: Cho, Yongin, et al.
Publicado: (2022) -
Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
por: Cho, Yongin, et al.
Publicado: (2022) -
Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus
por: Cho, Yongin, et al.
Publicado: (2023) -
The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
por: Oh, Hyunwoo, et al.
Publicado: (2023) -
Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
por: Lee, Yong-ho, et al.
Publicado: (2019)